ORAGENICS, INC. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share
ORAGENICS, INC. (OGEN) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share of $0.00 per share for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-13.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare · last filed 2019-03-29
- ORAGENICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2018-06-30 was $0.00.
- ORAGENICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2017-12-31 was $0.00.
- ORAGENICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- ORAGENICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- ORAGENICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2016 was $0.33.
- ORAGENICS, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic and diluted share for fiscal 2015 was $0.00.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 3 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 12 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|
| 2018-06-30 | $0.00 10-Q · filed 2018-08-13 | $0.00 10-Q · filed 2018-08-13 | ||||
| 2017-12-31 | $0.00 10-K · filed 2019-03-29 | |||||
| 2017-09-30 | $0.00 10-K · filed 2019-03-29 | |||||
| 2017-06-30 | $0.00 10-K · filed 2019-03-29 | $0.00 10-Q · filed 2018-08-13 | ||||
| 2017-03-31 | $0.00 10-K · filed 2019-03-29 | |||||
| 2016-12-31 | $0.00 10-K · filed 2018-02-16 | $0.33 10-K · filed 2018-02-16 | $0.03 10-K · filed 2017-02-27 | |||
| 2016-09-30 | $0.01 10-K · filed 2018-02-16 | $0.00 10-Q · filed 2016-11-14 | $0.03 10-Q · filed 2017-10-31 | |||
| 2016-06-30 | $0.35 10-K · filed 2018-02-16 | $0.04 10-Q · filed 2016-08-15 | $0.04 10-Q · filed 2017-08-14 | |||
| 2016-03-31 | $0.00 10-K · filed 2018-02-16 | |||||
| 2015-12-31 | $0.00 10-K · filed 2017-02-27 | $0.00 10-K · filed 2017-02-27 | ||||
| 2015-09-30 | $0.00 10-K · filed 2017-02-27 | $0.00 10-Q · filed 2016-11-14 | ||||
| 2015-06-30 | $0.00 10-K · filed 2017-02-27 | $0.00 10-Q · filed 2016-08-15 | ||||
| 2015-03-31 | $0.00 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |